Annovis Bio Inc (ANVS) financials · $80.4M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Annovis Bio Inc (ANVS) $80.4M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | N/A | N/A |
| Operating Income | -$29.7M | -$26.7M |
| Net Income | -$28.9M | -$24.6M |
| EPS (Diluted) | -$1.40 | -$2.31 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $21.1M | $13.9M |
| Cash & Equivalents | $19.5M | $10.6M |
| Total Liabilities | $4.23M | $4.62M |
| Current Liabilities | $3.64M | $3.88M |
| Shareholders' Equity | $16.9M | $9.31M |
| Retained Earnings | -$163.7M | -$134.8M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$25.6M | -$21.9M |
| Financing Cash Flow | $34.6M | $26.7M |
| Net Change in Cash | $8.98M | $4.80M |
FAQ
What is ANVS P/E and revenue?
Annovis Bio Inc (ANVS) $80.4M cap.
What is ANVS revenue?
ANVS income-statement cache has no revenue figure yet.
Is ANVS profitable?
Annovis Bio Inc last cached net income is -$28.9M (FY2025).
What are ANVS total assets?
Annovis Bio Inc last cached total assets are $21.1M (FY2025).
What is ANVS free cash flow?
No cached cash-flow row for ANVS yet.
Not investment advice. Cached statements, not a live tape.